Fesoterodine
| Use attributes for filter ! | |
| Molar mass | 411. 278 g/mol |
|---|---|
| ChemSpider ID | 5293755 |
| Trade name | Toviaz |
| Elimination half-life | 7–8 hours (active metabolite) |
| ATC code | G04BD11 (WHO) |
| License data | EMA |
| US | |
| FDA | |
| Music groups | Mirabegron |
| Solifenacin | |
| Tolterodine | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2605171 |
About Fesoterodine
Fesoterodine is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome. It was approved by the European Medicines Agency in April 2007, the US Food and Drug Administration on October 31, 2008 and Health Canada on February 9, 2012. Fesoterodine is a prodrug.